HTRA1遺伝子の変異は,年齢に関連する黄斑変性への感受性を高めます
Zhenglin Yang1, Nicola J Camp, Hui Sun
1Department of Ophthalmology and Visual Sciences, Moran Eye Center, University of Utah School of Medicine, Salt Lake City, UT 84132, USA.
Science (New York, N.Y.)
|October 21, 2006
まとめ
研究者らは,HTRA1遺伝子の特定の遺伝子変異体rs11200638を,年齢関連の黄斑変性 (AMD) の主要な遺伝的リスク因子として特定しました. この発見はHTRA1を強調しています.
科学分野:
- オフタルモロジック (眼科)
- 遺伝学 遺伝学とは
- 分子生物学は分子生物学である.
背景:
- 年齢関連の黄斑変性 (AMD) は,不可逆的な視力喪失の主要な原因です.
- AMDには重要な遺伝的要素があり,染色体10q26.6の既知のリスク局所があります.
- 10q26でのAMDリスクに起因する特定の遺伝子は未特定のままである.
研究 の 目的:
- 10q26場所でのAMDリスクに関連した因果遺伝子を特定する.
- AMDの病原性における特定の遺伝子変異の役割を調査する.
- AMD患者の候補遺伝子の発現と局所化を調査する.
主な方法:
- 581人のAMD症例と309人の対照群のゲノタイプ化.
- 10q26領域を中心とした単核性多形態化 (SNP) 分析.
- 患者サンプルにおけるHTRA1 mRNAとタンパク質発現の定量分析.
- HTRA1抗体を用いたドルーセンの免疫ヒストロケミカル染色.
主要な成果:
- HTRA1遺伝子のプロモーターの特定のSNP,rs11200638は,AMDの最も可能性の高い因果変種として特定されました.
- この変異は,AMDの49.3%の実質的な集団関連リスクをもたらします.
- リスクアレルを持つAMD患者のHTRA1 mRNAとタンパク質のレベルが上昇したのが観察されました.
- AMDの目のドルーセンでは,HTRA1.1に対する強い免疫マーキングが示されました.
結論:
- HTRA1遺伝子は,AMDの感受性において重要な役割を果たしています.
- HTRA1 の rs11200638 変異は,AMD リスクの増加と強く関連しています.
- HTRA1は,年齢関連の黄斑変性病変の病原性における潜在的な新しい経路を表しています.
さらに関連する動画
関連する概念動画
01:11Genetic Lingo
Overview
01:39Epistasis
In addition to multiple alleles at the same locus influencing traits, numerous genes or alleles at different locations may interact and influence phenotypes in a phenomenon called epistasis. For example, rabbit fur can be black or brown depending on whether the animal is homozygous dominant or heterozygous at a TYRP1 locus. However, if the rabbit is also homozygous recessive at a locus on the tyrosinase gene (TYR), it will have an unshaded coat that appears white, regardless of its TYRP1...
01:33Pleiotropy
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:11Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
01:28Human Genetics
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...